PARAGON 28 INC (FNA) Stock Price & Overview
NYSE:FNA • US69913P1057
The current stock price of FNA is 13.09 USD. Today FNA is down by 0%. In the past month the price increased by 0.46%. In the past year, price increased by 33.57%.
FNA Key Statistics
- Market Cap
- 1.099B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.63
- Dividend Yield
- N/A
FNA Stock Performance
FNA Stock Chart
FNA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to FNA. When comparing the yearly performance of all stocks, FNA is one of the better performing stocks in the market, outperforming 93.33% of all stocks.
FNA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FNA. While FNA seems to be doing ok healthwise, there are quite some concerns on its profitability.
FNA Earnings
On February 6, 2025 FNA reported an EPS of -0.13 and a revenue of 71.75M. The company missed EPS expectations (-6.82% surprise) and beat revenue expectations (0.3% surprise).
FNA Forecast & Estimates
10 analysts have analysed FNA and the average price target is 14.28 USD. This implies a price increase of 9.09% is expected in the next year compared to the current price of 13.09.
For the next year, analysts expect an EPS growth of 25.22% and a revenue growth 14.16% for FNA
FNA Groups
Sector & Classification
FNA Financial Highlights
Over the last trailing twelve months FNA reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS decreased by -10.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.79% | ||
| ROE | -41.84% | ||
| Debt/Equity | 0.84 |
FNA Ownership
FNA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.34 | 193.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.6 | 176.393B | ||
| SYK | STRYKER CORP | 24.5 | 141.687B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.84 | 108.246B | ||
| IDXX | IDEXX LABORATORIES INC | 41.77 | 49.421B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.22 | 48.681B | ||
| BDX | BECTON DICKINSON AND CO | 10.78 | 48.418B | ||
| RMD | RESMED INC | 20.79 | 37.195B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.35 | 35.143B | ||
| DXCM | DEXCOM INC | 28 | 27.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.91 | 18.52B | ||
| PODD | INSULET CORP | 38.01 | 16.95B | ||
| HOLX | HOLOGIC INC | 15.06 | 16.91B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About FNA
Company Profile
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 525 full-time employees. The company went IPO on 2021-10-21. The firm provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful, debilitating or even life-threatening conditions, it provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Its broad suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. The company has developed a comprehensive portfolio of foot and ankle surgical systems. Each system typically includes plates, screws, staples, nails, advanced joint and bone replacements, orthobiologics, and other implantation instruments and disposables specifically designed for the particular surgical system.
Company Info
PARAGON 28 INC
14445 Grasslands Drive
Englewood COLORADO US
Employees: 574
Phone: 17209121332
PARAGON 28 INC / FNA FAQ
What does FNA do?
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 525 full-time employees. The company went IPO on 2021-10-21. The firm provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful, debilitating or even life-threatening conditions, it provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Its broad suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. The company has developed a comprehensive portfolio of foot and ankle surgical systems. Each system typically includes plates, screws, staples, nails, advanced joint and bone replacements, orthobiologics, and other implantation instruments and disposables specifically designed for the particular surgical system.
What is the current price of FNA stock?
The current stock price of FNA is 13.09 USD.
Does FNA stock pay dividends?
FNA does not pay a dividend.
What is the ChartMill rating of PARAGON 28 INC stock?
FNA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for PARAGON 28 INC?
PARAGON 28 INC (FNA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the next earnings date for FNA stock?
PARAGON 28 INC (FNA) will report earnings on 2025-05-08, after the market close.